共 50 条
- [1] Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil®)[J]. Drugs, 2006, 66 (9) : 1263 - 1271Siddiqui M.A.A.Perry C.M.
- [2] Human Papillomavirus Quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®)A Viewpoint by Kevin A. Ault[J]. Drugs, 2006, 66 (9) : 1272 - 1273Kevin A. Ault
- [3] Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil®):: Profile report[J]. BIODRUGS, 2006, 20 (05) : 313 - 316Siddiqui, M. Asif A.Perry, Caroline M.
- [4] Human Papillomavirus Quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®)A Viewpoint by Kenneth H. Fife[J]. Drugs, 2006, 66 (9) : 1272 - 1272Kenneth H. Fife
- [5] Human Papillomavirus Quadrivalent (types 6,11, 16,18) Recombinant Vaccine (Gardasil®): Profile Report[J]. BioDrugs, 2006, 20 : 313 - 316M. Asif A. SiddiquiCaroline M. Perry
- [6] Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a guide to its use in the EU[J]. Drugs & Therapy Perspectives, 2015, 31 (1) : 1 - 8Keating G.M.McCormack P.L.
- [7] The Efficacy and Safety of the Quadrivalent Human Papillomavirus 6/11/16/18 Vaccine Gardasil[J]. JOURNAL OF ADOLESCENT HEALTH, 2011, 49 (05) : 467 - 475Haupt, Richard M.Sings, Heather L.
- [8] Efficacy of quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine (GARDASIL) in Japanese women aged 1826years[J]. CANCER SCIENCE, 2013, 104 (04) : 465 - 472Yoshikawa, HiroyukiEbihara, KeikoTanaka, YoshiyukiNoda, Kiichiro
- [9] Recalcitrant verruca plana responding to human papillomavirus quadrivalent (types 6,11,16, and 18) vaccine, recombinant[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB88 - AB88Funke, AlisaFowler, Joseph
- [10] Spotlight on Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®) in the Prevention of Premalignant Genital Lesions, Genital Cancer, and Genital Warts in Women[J]. BIODRUGS, 2011, 25 (05) : 339 - 343McCormack, Paul L.Joura, Elmar A.